dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['s1826', 'cml']
swog s1826. 1 yr pfs n-avd 94% vs 86% bv-avd. short median f/u 12mths. n-avd group sig higher neutropenia (gcsf mandated bv arm only, no inc infections). 1 in 10 pts had thyroid dysfunction. great to see a trial bridge adult and paediatric groups (&gt;12 yrs enrolled) #icml23 
Haematologist with clinical and academic interest in T-cell lymphoma. University Hospitals of Leicester.